Abstract Purpose: The mechanisms involved in the appearance of a second neoplasia in patients with Hodgkin's disease (HD) are probably related to the genomic damage induced by the treatments administered and its repair. Here, we searched for some constitutive molecular mechanisms that in a basal manner may influence the behavior of HD patients. Experimental Design: We aimed to evaluate with the Comet Assay whether baseline, induced, and unrepaired DNA damage differ between HD patients who did not develop a second neoplasia (HD-NST), HD patients who developed a second tumor (HD-ST), and healthy individuals; and to identify, through cDNA microarray hybridization, an expression signature of genes that could discriminate between the three groups. Results: Baseline, induced, and unrepaired DNA damage was higher in HD-ST than in HD-NST and higher in the second group than in healthy donors. The genomic approach revealed two sets of genes that discriminated between healthy subjects and patients and between the three sets of individuals. Hsp40, RAD50, TPMT, Rap2a, E2F2, EPHX2, TBX21, and BATF were validated by reverse transcription-PCR. Conclusions: Functional and genomic techniques revealed that alterations in cell cycle, repair, detoxification, and stress response pathways could be involved in the development of HD and in the occurrence of a primary second neoplasia in these patients. Both approaches may be useful as biological markers in the clinical setting.
Hodgkin's disease (HD) is a lymphoid neoplasia identified two centuries ago (1) . Its tumor component consists of Hodgkin's cells and Reed-Sternberg's cells. It is accepted that these cells originate in the B cells of the germinal center of lymph nodes (2) (3) (4) .
Epidemiologic and serologic studies have reported evidence of a relationship with the EBV (5) . The specific association of the virus with the neoplastic cells, its absence in normal lymphocytes, and the clonal integration of the virus into the Hodgkin's cells and Reed-Sternberg's cells are indicative of a mechanistic role of EBV in the transformation of Hodgkin's cells and ReedSternberg's cells (6, 7) .
The treatment is based on combined chemotherapy plus radiotherapy for early stages and on chemotherapy of differing intensities, with radiotherapy as consolidation in some cases, for advanced stages (8) .
The frequency of second tumors in these patients is higher than the incidence of primary tumors in the general population, one of the reasons for the higher mortality in treated HD patients (9) . The risk of appearance of a solid tumor depends on age at treatment and the treatments received. This increased risk has been attributed to the effect of irradiation (10) . The risk of lung cancer is higher and is dose-dependent in HD patients treated with radiotherapy, with or without chemotherapy (11) . The development of lung cancer is also associated with chemotherapy containing alkylating agents (12, 13) . Mantle radiotherapy received at young ages is associated with a risk of breast cancer 15 years or more later (14) .
The most frequent second malignancy associated with chemotherapy is acute nonlymphocytic leukemia. The risk of alkylatingrelated acute nonlymphocytic leukemia increases with increasing cumulative doses (15, 16) .
The mechanisms involved in the appearance of a second primary tumor in HD patients who have received radiotherapy, chemotherapy, or combined treatment are probably related to genomic damage. The treatments administered act as carcinogens and can alter the DNA structure and/or activities (17, 18) . Patients treated for HD have an excess risk of non-Hodgkin's lymphoma (19) . Appearance of solid tumors has also been associated with chemotherapy, such as cyclophosphamide-related bladder cancer or lung cancer, after treatments with alkylating compounds (20) .
Combination of radiotherapy and chemotherapy has a greater carcinogenic effect than just one type of treatment on the number of leukemias and solid tumors produced (9) . Remarkably, patients who have developed a first tumor are more susceptible to developing a second malignancy (21) that is not treatment related.
Searching for some constitutive molecular mechanisms that influence the behavior of HD patients, we undertook this study among our series of HD patients (22) with two objectives: (a) to investigate whether there are any differences in the baseline, X-radiation-induced, and repair capacity of DNA damage between HD patients that developed a second tumor (HD-ST), patients with HD that did not develop a second malignancy (HD-NST), and healthy subjects; and (b) to perform a gene profile trying to establish a differential expression signature between these subgroups.
Materials and Methods

Patients and samples
The study was designed using our database of 534 HD patients diagnosed in our hospital from January 1967 to December 2006. In this period, 76 patients developed a second tumor and 49 patients died for this reason (23) . During 2007, we contacted the 27 survivors and explained the purpose of our study, approved by the Ethical Board of our Hospital. Ten agreed to give us their informed consent. A blood sample of 10 cc was taken. Clinicopathologic characteristics are listed in Table 1A .
To recruit the control group of HD patients with no second tumor, we did not establish a matched series with the series of HD survivors who developed a second malignancy. We explained our objective to all HD patients on the basis of three selection criteria: (a) patients with a follow-up of >60 months since the end of treatment; (b) patients who were clinically checked in our Department during 2007; and (c) patients who showed no evidence of active disease. Nineteen gave their informed consent. A blood sample of 10 cc was extracted. Clinicopathologic characteristics are listed in Table 1B .
Translational Relevance
Through a functional technique (Comet Assay), we observed that constitutive damage, sensitivity to a carcinogen, and repair capabilities may modulate individual susceptibility to developing Hodgkin's Disease (HD). Additionally, the appearance of a second neoplasia in the HD patients correlates with the increase in these parameters.
Furthermore, through a genomic approach, we identified a set of genes related to cell cycle, repair, detoxification, and stress response pathways differentially expressed across healthy donors, HD patients who did not develop a second neoplasia, and HD patients who developed a second tumor. This set of genes could help us to identify the pathways altered in HD tumorigenesis and in the appearance of a second primary tumor.
Moreover, functional and genomic approaches could be used in the clinical setting as biological markers not only of the development of HD but also of the occurrence of a primary second neoplasia in these patients. Abbreviations: MOPP, Nitrogen mustard, vincristine, procarbazine, and prednisone; ABVD, Adriamycin, bleomycin, vinblastine, and dacarbazine; RT, radiotherapy; CT, chemotherapy; NSCLC, non-small cell lung cancer; GIST, gastrointestinal stromal tumor.
Blood samples from 20 healthy donors were obtained from the hematology unit, as non-Hodgkin's population control.
Lymphocyte cultures
Lymphocytes were isolated by standard procedures (Lymphoprep, ATOM, AXIS-SHIELD PoC AS), pooled, and stored in liquid nitrogen. Cultures were established in T-25 flasks using RPMI 1640 with 20% FCS and antibiotics and incubated for 72 h. Viability was checked with Trypan Blue.
Alkaline single-cell gel electrophoresis (Comet Assay) We followed the protocol of Singh et al. (24) . Superfrosted and precleaned microscope slides (Fisher Scientific) were immersed in 1% normal-melting-point agarose dissolved in PBS (pH 7.4) and allowed to dry. Five microliters of a cell suspension containing approximately 20,000 cells were mixed with 0.5% low-melting-point agarose, kept at 37°C, and spread on an agarose-precoated slide. A third layer of lowmelting-point agarose was added. Cells were lysed for 1 h at 4°C in buffer (pH 10) containing 2.5 mol/L NaCl, 100 mmol/L EDTA, 100 mmol/L Trizma base, 10% DMSO, and 1% Triton X-100, rinsed in 0.4 mol/L Tris-HCl (pH 7.5) and placed on a electrophoretic unit (Owl Separation Systems, Inc.) without power for 30 min in alkaline buffer [300 mmol/L NaOH and 1 mmol/L EDTA (pH >13)] at 4°C. Electrophoresis was carried out for 45 min at 25 V, 295 to 300 mAmp, and a recirculating flow of 100 mL/min. All steps were carried out in the dark. Slides were rinsed in neutralization buffer [0.4 mol/L Tris-HCl (pH 7.5)], fixed in cold 100% ethanol, and air dried.
Source of X-radiation X-Rays were delivered by a 60 Co irradiator source. Cells were irradiated at 2 Gy on ice. From previous dose-response experiments (data not shown), we determined that 2 Gy was the optimal dose to induce DNA damage. Repair studies required incubation of the irradiated cells in culture media at 37°C in 5% CO 2 for 5 and 15 min before lysis.
Quantification of DNA damage Slides were stained with 50 μL of a 1 μg/mL 4′,6-diamidino-2-phenylindole solution. Observations were made at ×20 magnification [Olympus BX51 microscope (Olympus España) connected to a CoHu 4912 CCD camera (CoHu, Inc.). One hundred cells (50 from each duplicate slide) were randomly selected, avoiding borders, and quantified by Komet 5.5 image analysis software (Kinetic Imaging Ltd.). Nondetectable cell nuclei, clouds, and hedgehogs were not scored. Extent of damage was measured quantitatively by the tail moment (TM; the product of the percentage of DNA in the comet tail and the tail length) and the tail intensity (TI; percentage of DNA in the tail). Results were expressed as the mean of TMs and TIs of 100 cells from two duplicate slides.
RNA isolation and quality control Total RNA was extracted by the RNeasy Mini kit (Quiagen, Inc.) and treated with RNase-free DNase (Ambion, Inc.). Quality was determined with a 2100 Bioanalyzer (Agilent Technologies). RNA amount was established with a NanoDrop spectrophotometer (NanoDrop).
For each population, three different pooled samples were obtained by mixing equal amounts of RNA from three individual samples of each series (healthy individuals, HD-ST, and HD-NST). The sample used as the common reference in microarray hybridizations was obtained by mixing equal amounts of RNA from the healthy donors of samples.
In vitro transcription and RNA amplification RNA amplification and labeling was carried out by the Low RNA Input Linear Amplification PLUS, Two-Color kit (Agilent Technologies). Two micrograms of total RNA input were amplified in two rounds of amplification. First-strand cDNA syntheses and amplification reactions were carried out with random and T7 primers, respectively. During the 2-h in vitro transcription, Cy3-or Cy5-labeled CTP was introduced into each amplified RNA (cRNA) from Reference and pooled samples, respectively. Products of the reaction were purified using RNeasy mini spin column (Qiagen).
Hybridization and slide processing
We used Agilent 44K 60-mer oligo microarray slides (Agilent Technologies). Procedures of hybridization, slide, and image processing were carried out according to the Two-Color Microarray-based Gene Expression Analysis protocol. In each experiment, 825 ng of contrasting cRNA samples were fragmented at 60°C for 30 min and hybridized at 65°C for 17 h. The slides were then washed, dried, and scanned at a resolution of 10 μm with Agilent G2565BA Micro-array Scanner (Agilent Technologies).
Scanning and result analyses
ANOVA was run on hybridization data regrouped in three different condition groups: hybridizations of healthy samples versus reference, hybridizations of HD-NST versus reference, and hybridizations of HD-ST versus reference. Benjamini and Hochberg multiple testing correction procedure (25) was applied to keep the false discovery rate under 10% and the Tukey Post Hoc Test was used to determine which specific group pairs were statistically different from each other.
Real-time reverse transcription-PCR validation
Primers for HSP40, RAD50, TPMT, TBX21, XRCC3, EPHX2, POLG2, RAP2A, E2F2, and BATF were designed with the Primer Express software (Applied Biosystems; Table 2 ). Housekeeping genes, TATA binding protein (TBP), succinate dehydrogenase complex subunit A (SDHA), and ubiquitin C (UBC) were used to normalize gene expression (26) . Messenger RNA levels are expressed in relation to the geometric average of the housekeeping genes (26) . Concentrations of target and housekeeping genes were calculated by interpolation, using a standard curve generated from a serial dilution of cDNA of an individual expressing the specific gene 
Abbreviations: F, forward; R, reverse; AT, annealing temperature.
analyzed. Four hundred nanograms of total RNA was reverse-transcribed using the Gold RNA PCR Core kit (Applied Biosystems). Real-time PCR was done in a Light-Cycler 480 apparatus (Roche Diagnostics) using the LightCycler R 480 SYBR Green Master kit (Roche Diagnostics). Annealing temperature for each reaction is described in Table 2 . Melting curve analyses and electrophoresis of the products were done to confirm the generation of the specific product. Bands were sequenced in an ABI Prism 377 DNA sequencer (PE Applied Biosystems).
Statistical analysis
Comet Assay measurements and gene expression data were shown after log 10 transformation. Variables were contrasted by ANOVA or Pearson correlation coefficient. When the distribution was not normalized using log 10 transformation, Spearman coefficient correlation was used. Twotailed P values of ≤0.05 were considered statistically significant. Statistical analysis used SPSS 13.0 statistical software (SPSS, Inc.).
Results
Baseline damage, response to X-radiation, and repair capability. The baseline level of DNA damage was statistically significantly higher in HD-ST than in HD-NST and, in the second group, higher than in healthy donors for TI and TM (P < 0.01; Table 3 ). Similarly, X-radiation-induced DNA damage was statistically significantly higher in HD-ST than in HD-NST and higher in the second group than in control subjects for TI (P < 0.01; Table 3 ). Equally, unrepaired X-radiation-induced DNA damage after 5 and 15 minutes of recovery was statistically significantly higher in HD-ST than in HD-NST and was higher in the second group than in healthy individuals for TI and TM (P < 0.01; Table 3 ).
Genomic approach and reverse transcription-PCR validation. Differential gene expression analysis evaluated by cDNA microarray hybridization identified a total of 95 and 1,396 genes that could discriminate between healthy subjects and patients and between the three sets of individuals, respectively (Data have been submitted to Gene Expression Omnibus, accession number: GSE12103). We focused on those genes relating to cell cycle, stress response, repair, and detoxifying pathways. On the basis of signal intensity and P value, we selected 10 of these genes for quantitative reverse transcription-PCR (RT-PCR) validation (Table 4 ). The selected genes involved in cell cycle were RAP2A, E2F2, TBX21, and BATF; in stress response, Hsp40; in repair, Rad50, XRCC3, and POLG2; and in detoxification, TMPT and EPHX2. We confirmed for RT-PCR the following: TMPT, TBX21, EPHX2, E2F2, and BATF (Table 4 ). In the microarray analysis, Hsp-40 expression levels were found lower in HD-ST patients than in the HD-NST group and lower in the latter group than in healthy donors. In the RT-PCR validation, we found Hsp-40 downregulated in the cancer patients more than in the control subjects, but its expression could not discriminate between HD-ST and HD-NTS (Table 4) . Similarly, Rad 50 and Rap2A levels were higher in the HD-ST patients than in the HD-NST group and higher in the latter group than in healthy donors. In the RT-PCR validation, we found Rad 50 and Rap2A more up-regulated in the cancer patients than in control subjects, but their expression did not discriminate between the two groups of cancer patients (Table 4) . Curiously, Rad50 expression levels were significantly higher in HD-ST than in HD-NST subjects (Table 4) . Association between genomic and functional data. The correlations observed between the expression levels of the genes analyzed and the functional parameters measured by the Comet Assay are shown in Table 5 . Briefly, a direct statistically significant correlation was observed between expression of TPMT and levels of baseline, induced, and unrepaired DNA damage. Similarly, direct associations were found between expression levels of TBX21 and E2F1 and the amount of residual damage after 5 and/or 15 minutes recovery from the X-radiation insult. In addition, a direct statistical correlation was observed between RAP2A expression and baseline and unrepaired damage. Interestingly, EPHX2 and Hsp40 expressions inversely correlated with baseline and residual DNA damage levels. No other correlations were identified.
Discussion
The fact that baseline damage was higher in the peripheral blood lymphocytes from HD-ST than from HD-NST and higher in the second group than in healthy individuals indicates that HD-ST may have less capacity to limit endogenous damage than HD-NST and healthy donors, possibly due to inherited less efficient detoxifying and repair pathways. This could facilitate the accumulation of mutations and the development of Hodgkin's lymphoma. Additionally, the higher the baseline damage is, the greater the possibility of developing a second neoplasia. Cumulative damage in the lymphocytes' genome due to exposure to the treatments given is another possible explanation for these findings. On this, data in the literature are inconclusive. Whereas some authors observed that induced damage with chemotherapy or radiotherapy returned to pretreatment values in a short term (27, 28) , other reports show the persistence of the injury in the lymphocytes (28, 29) . Very few publications show long followup periods. However, as lymphocytes' half-life is limited, any cumulative injury to their DNA should be due to permanent damage caused to the cell renewal systems. This has not been shown, although there is evidence of stem cell recovery from certain types of genomic damage after a short period of time (30) .
As X-radiation is a common therapy in HD patients, we challenged the lymphocytes from the three groups with this agent.
Low doses of ionizing radiation produce DNA single-strand breaks that can be removed mainly by the base excision repair pathway. Additional damage could be caused by by-products generated by X-radiation. The HD-ST patients were more sensitive to X-rays than HD-NST individuals, with healthy donors being the most resistant. This sensitivity may reflect the effectiveness of the mechanisms involved in the neutralization of the above-mentioned by-products.
Unrepaired damage was higher in HD-ST patients than in HD-NST and higher in the latter group than in healthy individuals, suggesting that base excision repair may be compromised in HD-ST individuals. Thus, constitutive damage, sensitivity to a carcinogen and repair capabilities may modulate individual susceptibility to developing HD. In addition, the appearance of a second neoplasia correlates with the increase in these parameters.
Concerning the genomic approach, we validated for RT-PCR that Hsp40, RAD50, TPMT, Rap2a, and E2F2 discriminated between cancer and healthy individuals. EPHX2, TBX21, and BATF were differentially expressed in the three groups. The transcription factors E2F2, TBX21, and BATF (31-33) and the RAS family member, Rap2a (34), modulate differentiation and/or cellular growth and in our series were overexpressed in the lymphoma patients. TBX21 was previously found up-regulated in Hodgkin's patients and proposed as a diagnosis marker (35) . Our results suggest that levels of TBX21 could also be used as a marker for the development of a second neoplasia in HD patients. EPHX2 is a phase II drug-metabolizing enzyme (36) whose expression gradually decreases from HD-ST to HD-NST and healthy donors. Low levels of the enzyme may negatively influence the detoxification of epoxide substrates and favor the accumulation of mutations. TPMT is another enzyme involved in the metabolism of certain chemotherapeutic agents (37) . It is intriguing that TPMT is up-regulated in the group of patients because its overexpression should be related to greater detoxifying efficiency and to a lower rate of accumulation of mutations. Additionally, direct correlation was observed between its expression and the amount of DNA damage (baseline and unrepaired). Hsp40 is a cochaperone induced after certain types of cell stress such as oxidative damage (38) . Although, in general, chaperone up-regulation is involved in tumorigenesis (38), we found Hsp40 more down-regulated in Table 5 . Correlations between expression levels of the genes validated by RT-PCR and the functional data lymphoma patients than in the healthy individuals. Moreover, inverse significant correlations were observed between Hsp40 expression and DNA damage levels (baseline and unrepaired). Intriguingly, Rad50, involved in repair of double-strand breaks, was overexpressed in our group of patients versus healthy donors, although no associations were found between its levels and functional measurements. The finding that TMPT and Rad50 were lower and Hsp40 greater in HD-ST patients than in HD-NST patients, although for TMPT and Hsp40 the difference is not statistically significant, is relevant. We probably do not yet know the precise function of these proteins in the HD context, especially their interactions with other pathways. Briefly, we identified a set of genes differentially expressed across healthy donors, HD-NST and HD-ST. This set of genes could help us to identify the pathways altered in HD tumorigenesis and in the appearance of a second primary tumor. It could also be used as a clinical marker, particularly in those patients treated for HD and with more inefficient detoxifying and/or repair pathways, who could be introduced into special surveillance programs. Through functional and genomic techniques, we found that alterations in cell cycle, repair, detoxification, and stress response pathways could be involved in the development of HD and in the occurrence of a primary second neoplasia. Additionally, both approaches may be useful as biological markers in the clinical setting.
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